Smrt majki povezana s COVID-19: sistematski pregled i metaanaliza fokusirana na komorbiditete i kliničke karakteristike majke.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Sažetak istraživanja
Istorijat Pored smanjenja kvaliteta akušerske nege, direktan uticaj COVID-19 na trudnoću i postporođaj je neizvestan.
Cilj Procijeniti karakteristike trudnica koje su umrle od COVID-19. Strategija pretraživanja Cochrane Library, Embase, MEDLINE, Scopus i Google Scholar pretraživani su od početka do februara 2021. Kriterijumi odabira Studije koje su upoređivale preminule i preživjele trudnice s COVID-19. Prikupljanje i analiza podataka Relevantni podaci su izdvojeni i tabelarno prikazani. Primarni ishod bio je komorbiditet majke. Glavni rezultati Uključeno je trinaest studija sa 154 preminula pacijenta. Gojaznost je udvostručila rizik od smrti (relativni rizik [RR] 2,48, 95% interval pouzdanosti [CI] 1,41-4,36, I 2 = 0%). Nisu pronađene razlike za gestacijski dijabetes (RR 5,71; 95% CI 0,77-42,44, I 2 = 94%) ili astmu (RR 2,05, 95% CI 0,81-5,15, I 2 = 0%). Sveukupno, najmanje jedan teški komorbiditet pokazao je dvostruko povećan rizik od smrti (RR 2,26, 95% CI 1,77-2,89, I 2 = 76%). Prijem na intenzivnu njegu bio je povezan sa petostruko povećanim rizikom od smrti (RR 5,09, 95% CI 2,00-12,98, I 2 = 56%), bez razlike u potrebi za respiratornom podrškom (RR 0,53, 95% CI 0,23-1,48, I 2 = 95%) ili 4% mehaničke ventilacije (RR 95%). 0,96-19,60, I 2 = 58%).
Zaključak COVID-19 s najmanje jednim komorbiditetom povećava rizik od intenzivne njege i smrtnosti.
Prikaži originalni naslov i sažetak na engleskom
Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics.
Background Besides reducing the quality of obstetric care, the direct impact of COVID-19 on pregnancy and postpartum is uncertain.
Objective To evaluate the characteristics of pregnant women who died due to COVID-19. Search strategy Cochrane Library, Embase, MEDLINE, Scopus, and Google Scholar were searched from inception to February 2021. Selection criteria Studies that compared deceased and survived pregnant women with COVID-19. Data collection and analysis Relevant data were extracted and tabulated. The primary outcome was maternal co-morbidity. Main results Thirteen studies with 154 deceased patients were included. Obesity doubled the risk of death (relative risk [RR] 2.48, 95% confidence interval [CI] 1.41-4.36, I 2 = 0%). No differences were found for gestational diabetes (RR 5.71; 95% CI 0.77-42.44, I 2 = 94%) or asthma (RR 2.05, 95% CI 0.81-5.15, I 2 = 0%). Overall, at least one severe co-morbidity showed a twofold increased risk of death (RR 2.26, 95% CI 1.77-2.89, I 2 = 76%). Admission to intensive care was related to a fivefold increased risk of death (RR 5.09, 95% CI 2.00-12.98, I 2 = 56%), with no difference in need for respiratory support (RR 0.53, 95% CI 0.23-1.48, I 2 = 95%) or mechanical ventilation (RR 4.34, 95% CI 0.96-19.60, I 2 = 58%).
Conclusion COVID-19 with at least one co-morbidity increases risk of intensive care and mortality.
Izvorni podaci
- DOI
- 10.1002/ijgo.13726
- PMID
- 33930185
- PMCID
- PMC9087672
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom